How Revitol AntiAging Wrinkle Cream Works

If you are like most men and women, you are looking to have healthier and more youthful looking skin. Revitol Complete anti wrinkle cream can make you look to years younger and bring back the youthfulness of your earlier years.

What Makes the Revitol Anti Wrinkle Cream Work So Well?

Revitol works to remove wrinkles, make skin firmer and tighter, and reduce the superficial effects of aging. Revitol is made of patented ingredients that stimulate the productiton of healthy new skin cells on an ongoing basis, unlike the temporary results seen with costly and repetitive procedures such as microdermabrasion.

Revitol's natural anti wrinkle cream delivers a blend of unique proven skin repairing and revitalizing agents that lift up, hydrate, smooth out, and reduce facial lines making our anti aging product second to none.

Studies on Ingredients in Revitol Anti Aging Cream :

Balazs, E.A. and Laurent, T.C., (1998). Round Table Discussion: New Applications for Hyaluronan, In: Laurent, T.C. (ed.), The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives, pp., Portland Press, London .
Band, P.A., (1998). Hyaluronan Derivatives: Chemical and Clinic Applications, In: Laurent, T.C. (ed.), The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives, pp. 33–42, Portland Press, London .
Bergamasco, B. and Scarzella, L., Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type, Funct Neurol 1994 May-Jun;9(3):161-8.
Danysz, A., Smietanski, J. and Panek, W., The influence of 2-dimethylaminoethanol (DMAE) on the mental and physical efficiency in man. Act Nerv Super (Praha). 1967 Nov;9(4):417.
Farris, P., Cosmeceuticals: a review of the science behind the claims. Cosmetic Dermatol. 2003;16(3):59-70.
Fisman, M., Mersky, H. and Helmes, E., Double-blind trial of 2-dimethylaminoethanol in Alzheimer’s disease. Am J Psychiatry. 1981 Jul;138(7):970-2.
Gillis, J.C., Benefield, P. and McTavish, D., Idebenone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders, Drugs Aging 1994; Aug;5 (2): 133-152.
Gutzmann, H. and Hadler, D., Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study, J Neural Transm Suppl 1998;54:301-10.
Ikejiri, Y., Mori, E., Ishii, K., Yasuda, M. and Sasaki, M., Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS, Neurology 1996; Aug 47(2); 583-585.
Kligman, A.M., Grove, G..L, Hirose, R. and Leyden, J.J., Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986;15(4 Pt 2):836-859.
Knudson, C.B. and Knudson, W., (1993). Hyaluronan-binding Proteins in Development, Tissue Homeostasis, and Disease , FASEB J., 7: 1233–1241.
Laurent, T.C. and Fraser, J.R.E., (1992). Hyaluronan, FASEB J. 6: 2397–2404.
Lerman-Sagie, T., Rustin, P. and Lev, D. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone, J Inherit Metab Dis 2001 Feb;24(1):28-34.
Pentapeptide offers improvement in human photoaged facial skin. 20th World Congress of Dermatology (204 subjects - 14 weeks).
Perry, E., Walke,r M., Grace, J. and Perry, R., Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999 Jun;22(6):273-80.
Ranen, N.G. and colleagues, A controlled trial of idebenone in Huntington's disease, Mov Disord 1996 Sep; 11(5):549-554.
Relevance of antiwrinkle treatment of a peptide: 4 months clinical double blind study vs excipient. 20th World Congress of Dermatology (60 subjects - 4 mos.)
Stein, J. (2002a). WCD: Palmitoyl pentapeptide challenges Retinol as a treatment for photo-aged skin. July 3: www.pslgroup.com/dg/2177e6.htm.
Stein, J. (2002b). WCD: Palmitoyl pentapeptide improves photo-aged skin.
Uhoda, I., Faska, N., Robert, C., Cauwenbergh, G. and Pierard, G.E., Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Res Technol. 2002 Aug;8(3):164-7.
Weyer, G., Babeji-Dolle, R.M., Hadler, D., Hofmann, S. and Herrmann, W.M., A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease, Neuropsychobiology 1997; 36(2):73-82.
Zs-Nagy, I., Pharmacological interventions against aging through the cell plasma membrane: a review of the experimental results obtained in animals and humans. Ann N Y Acad Sci. 2002 Apr;959:308-20.